Skip to main content
SpringerLink
Log in

Immunohistochemical Expression of p53, MDM2, and p21Waf1 Oncoproteins in Endometriomas But Not Adenomyosis

  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

p53, MDM2, and p21Waf1 are oncoproteins that regulate the cell cycle. The purpose of this study was to examine the distribution of p53, MDM2, and p21Waf1 oncoprotein expression in endometriomas and in adenomyosis.

Methods

Tissue samples from 25 women with pathologically confirmed endometriomas and 3 1 women with pathologically confirmed adenomyosis were analyzed. Expression of p53, MDM2, and p21Waf1 oncoproteins was assessed by immunohistochemical nuclear staining.

Results

p53, MDM2, and p21Waf1 expression were detected in 20%, 60%, and 80%) of endometrioma tissue samples, respectively. All endometrioma tissue samples expressing p53 also tested positive for both MDM2 and p21Waf1. MDM2 expression was significantly higher in the proliferative than in the secretory phase of the cycle. In contrast, all 31 adenomyosis tissue samples were negative for p5 3, MDM2, and p21Waf1 expression.

Conclusion

The expression of p53, MDM2, and p2lWaf1 suggests a role for these oncoproteins in the regulation of endometrioma cell growth, but not in adenomyosis. (J Soc Gynecol Investig 2005; 12: 263— 6) Copyright © 2005 by the Society for Gynecologic Investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harada T, Kaponis A, Iwabe T, et al. Apoptosis in human endometrium and endometriosis. Hum Reprod Update 2004;10:29–38.

    Article  CAS  Google Scholar 

  2. Garcia-Velasco J, Arici A. Apoptosis and the pathogenesis of endometriosis. Semin Reprod Med 2003;21:165–72.

    Article  CAS  Google Scholar 

  3. Witz CA. Pathogenesis of endometriosis. Gynecol Obstet Invest 2002;53:52–62.

    Article  Google Scholar 

  4. Seli E, Berkkanoglu M, Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am 2003;30:41–61.

    Article  Google Scholar 

  5. Arici A, Matalliotakis I, Goumenou A, Koumantakis G, Vassiliadis S, Mahutte NG. Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis. Fertil Steril 2003;80:889–94.

    Article  Google Scholar 

  6. Koumantakis E, Matalliotakis I, Neonaki M, Froudarakis G, Georgoulias V. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Arch Gynecol Obstet 1994;255:107–12.

    Article  CAS  Google Scholar 

  7. Vogelstein B, Kanzler KW. p53 function and dysfunction. Cell 1992;70:523–6.

    Article  CAS  Google Scholar 

  8. Roemer K, Friedmann T. Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by re-constitution of p53 function. Ann NY Acad Sei 1994; 716:265–80.

    Google Scholar 

  9. Cadwell C, Zambetti GP. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 2001;277:15–30.

    Article  CAS  Google Scholar 

  10. Chang F, Syijanen S, Syrjanen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995;13:1009–22.

    Article  CAS  Google Scholar 

  11. Wu X, Bayle JH, Olson D, Levme AJ. The p53-mdm-2 auto-regulatory feedback loop. Genes Dev 1993;7:1126–32.

    Article  CAS  Google Scholar 

  12. Haupt Y, Maya R, Kazaz A, Oren M. MDM2 promotes the rapid degradation of p53. Nature 1997;387:296–9.

    Article  CAS  Google Scholar 

  13. Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sei 1999;55:96–107.

    Article  CAS  Google Scholar 

  14. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817–25.

    Article  CAS  Google Scholar 

  15. El-Deiry WS, Harper JW, O’connor PM, et al. WAFl/CIPl is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169–74.

    CAS  PubMed  Google Scholar 

  16. Valassiadou KE, Stefanaki K, Tzardi M, et al. Immunohistochemical expression of p53, bcl-2, MDM2 and wafl/p21 proteins in colorectal adenocarcinomas. Anticancer Res 1997;17:2571–6.

    CAS  PubMed  Google Scholar 

  17. Plisiecka-Halasa J, Karpinska G, Szymanska T, et al. P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens. Ann Oncol 2003; 14:1078–85.

    Article  CAS  Google Scholar 

  18. Milde-Langosch K, Hagen M, Bamberger Am, Loning T. Ex-pression and prognostic value of the cell-cycle regulatory pro-teins, Rb, pl6MTSl, p21WAFl, p27KIPl, cyclin E, and cyclin D2, in ovarian cancer. Int J Gynecol Pathol 2003;22:168–74.

    Article  Google Scholar 

  19. Ferrandina G, Stoler A, Fagotti A, et al. p21WAFl/CIPl protein expression in primary ovarian cancer. Int J Oncol 2000;17:1231–5.

    CAS  PubMed  Google Scholar 

  20. Taskin M, Lallas TA, Shevchuk M, Barber HR. P53 expression in adenomyosis in endometrial carcinoma patients. Gynecol On-col 1996;62:241–6.

    CAS  Google Scholar 

  21. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351–2.

    Article  Google Scholar 

  22. Molitor JJ. Adenomyosis: A clinical and pathological appraisal. Am J Obstet Gynecol 1971;110:275–84.

    Article  CAS  Google Scholar 

  23. Harada M, Suganuma N, Furuhashi M, et al. Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 1996;2:307–15.

    Article  CAS  Google Scholar 

  24. Giannikaki E, Kouvidou C, Tzardi M, et al. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins MDM2 and p21/wafl. Anticancer Res 1997;17:2123–7.

    CAS  PubMed  Google Scholar 

  25. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Housei ME. Induction of p21 (WAF-1/CIP1) during differ-entiation. Oncogene 1994;9:3389–96.

    CAS  PubMed  Google Scholar 

  26. Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R. MDM2 is a negative regulator of p21WAFl/CIPl, independent ofp53. J Biol Chem 2004;279:16000–6.

    Article  CAS  Google Scholar 

  27. Bischoff FZ, Heard M, Simpson JL. Somatic DNA alterations in endometriosis: High frequency of chromosome 17 and p53 loss in late-stage endometriosis. J Reprod Immunol 2002;55:49–64.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Dartmouth Medical School, One Medical Center Dr., Lebanon, NH, 03756, USA

    Anastasia Goumenou MD, PhD, Ioannis Panayiotides MD, PhD, Neal G. Mahutte MD (Assistant Professor of Reproductive Endocrinology and Infertility), Ioannis Matalliotakis MD, PhD, Yvoni Fragouli MD, PhD & Aydin Arici MD

  2. Department of Pathology and Department of Hygiene and Epidemiology, Uni¬versity of Athens, Athens, Greece

    Anastasia Goumenou MD, PhD, Ioannis Panayiotides MD, PhD, Neal G. Mahutte MD (Assistant Professor of Reproductive Endocrinology and Infertility), Ioannis Matalliotakis MD, PhD, Yvoni Fragouli MD, PhD & Aydin Arici MD

  3. Division of Reproductive Endocrinology and Infer¬tility, Department of Obstetrics and Gynecology, Dartmouth Medical School, Lebanon, New Hampshire, USA

    Anastasia Goumenou MD, PhD, Ioannis Panayiotides MD, PhD, Neal G. Mahutte MD (Assistant Professor of Reproductive Endocrinology and Infertility), Ioannis Matalliotakis MD, PhD, Yvoni Fragouli MD, PhD & Aydin Arici MD

  4. Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA

    Anastasia Goumenou MD, PhD, Ioannis Panayiotides MD, PhD, Neal G. Mahutte MD (Assistant Professor of Reproductive Endocrinology and Infertility), Ioannis Matalliotakis MD, PhD, Yvoni Fragouli MD, PhD & Aydin Arici MD

Authors
  1. Anastasia Goumenou MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioannis Panayiotides MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neal G. Mahutte MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ioannis Matalliotakis MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yvoni Fragouli MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aydin Arici MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neal G. Mahutte MD.

Additional information

This work was supported by funds from the University of Crete.

The authors would like to thank Professor G. Delides, Chief of the Department of Pathology at the University of Crete, for his contribution to this work. We are also grateful for excellent technical support received from Elli Karidi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goumenou, A., Panayiotides, I., Mahutte, N.G. et al. Immunohistochemical Expression of p53, MDM2, and p21Waf1 Oncoproteins in Endometriomas But Not Adenomyosis. Reprod. Sci. 12, 263–266 (2005). https://doi.org/10.1016/j.jsgi.2005.01.028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.jsgi.2005.01.028

Key words

Search

Navigation